Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy

Metabolically Healthy Obesity (MHO) is generally recognized as the absence of any metabolic disorders and cardiovascular diseases, including type 2 diabetes, dyslipidemia, and hypertension, in obese individuals; however, it is not clearly defined. Therefore, the present study investigated difference...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Shiori Kawai, Hajime Yamakage, Kazuhiko Kotani, Mitsuhiko Noda, Noriko Satoh-Asahara, Koshi Hashimoto
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	The Japan Endocrine Society 2023-12-01
Seri Bilgileri:	Endocrine Journal
Konular:	metabolically healthy obesity (mho) metabolically unhealthy obesity (muo) weight reduction therapy cystatin c adiponectin
Online Erişim:	https://www.jstage.jst.go.jp/article/endocrj/70/12/70_EJ23-0189/_html/-char/en
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!